Paul van der Leest
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 13
-
- Pancreatic and Hepatic Oncology Research 3
- Cancer Immunotherapy and Biomarkers 3
-
- Lung Cancer Treatments and Mutations 7
- Renal cell carcinoma treatment 3
-
- Genetic factors in colorectal cancer 5
-
- Single-cell and spatial transcriptomics 2
- CRISPR and Genetic Engineering 1
- Co-authors
- Ed SchuuringHarry J.M. GroenLéon C.L.T. van KempenMenno TammingaT. Jeroen N. HiltermannArja ter ElstWim TimensGrigory Sidorenkov
- Journals
- International Journal of Molecular Sciences (2 papers)Clinical Chemistry (4 papers)Cancers (2 papers)
- Partner nations
- NetherlandsGermanyFrance
In The Last Decade
Paul van der Leest
12 papers receiving 222 citations
Peers
Comparison fields: 5 of 36
- Cancer Research 184
- Oncology 101
- Pulmonary and Respiratory Medicine 110
- Pathology and Forensic Medicine 50
- Molecular Biology 71
Countries citing papers authored by Paul van der Leest
This map shows the geographic impact of Paul van der Leest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul van der Leest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul van der Leest more than expected).
Fields of papers citing papers by Paul van der Leest
This network shows the impact of papers produced by Paul van der Leest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul van der Leest. The network helps show where Paul van der Leest may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul van der Leest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 18 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 17 | |
| 8 | 2022 | 18 | |
| 9 | 2022 | 18 | |
| 10 | 2021 | 45 | |
| 11 | 2021 | 23 | |
| 12 | 2020 | 23 | |
| 13 | 2020 | 46 |
About Paul van der Leest
Paul van der Leest is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 13 papers that have together received 222 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (7 papers), Genetic factors in colorectal cancer (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Renal cell carcinoma treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Single-cell and spatial transcriptomics (2 papers) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Cancer Research (184 citations), Oncology (101 citations) and Pulmonary and Respiratory Medicine (110 citations). Paul van der Leest has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include Ed Schuuring, Harry J.M. Groen, Léon C.L.T. van Kempen, Menno Tamminga, T. Jeroen N. Hiltermann, Arja ter Elst, Wim Timens, Grigory Sidorenkov, Anna K.L. Reyners and Ellen Heitzer. Their work appears in journals such as International Journal of Molecular Sciences, Clinical Chemistry and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.